cyclopentane has been researched along with Parkinson Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Fujimoto, S; Imai, G; Imai, H; Matsuzono, K | 1 |
| Di Maio, R; Graham, SH; Gronenborn, AM; Kodali, RB; Koharudin, LM; Liu, H | 1 |
| Bednar, RA; Cunningham, ME; Dilella, AG; Fandozzi, C; Fay, JF; Kelly, MJ; Koblan, KS; Layton, ME; Liang, A; Lis, EV; McDonald, TP; Mosser, SD; Reiss, DR; Rodzinak, KJ; Sanderson, PE; Seabrook, GR; Trainor, N; Urban, MO; Wang, H; Yergey, J; Young, SD | 1 |
| Dagaev, SG; Dolgo-Saburov, VB; Dukhovich, FS; Gorbatova, EN | 1 |
| SANYAL, RK | 1 |
| LEIGH, D; SCHWAB, RS | 2 |
| WINTHER, K | 1 |
| COBB, CT; LEIGH, D; SCHWAB, RS | 1 |
| SCHWAB, RS; TILLMANN, WR | 1 |
| Fei, XF; Gu, ZL; Li, LY; Liang, ZQ; Qin, ZH; Zhao, XL | 1 |
11 other study(ies) available for cyclopentane and Parkinson Disease
| Article | Year |
|---|---|
Malignant syndrome triggered by influenza A virus infection in a patient with Parkinson's disease with improvement after intravenous peramivir treatment.
Topics: Acids, Carbocyclic; Administration, Intravenous; Aged; Antiparkinson Agents; Antiviral Agents; Cyclopentanes; Disease Progression; Guanidines; Humans; Influenza A virus; Influenza, Human; Male; Parkinson Disease; Syndrome | 2019 |
Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1.
Topics: Animals; Cyclopentanes; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Mutation; Parkinson Disease; Prostaglandin D2; Protein Denaturation; Rats; Rats, Sprague-Dawley; Ubiquitin Thiolesterase | 2010 |
Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonists.
Topics: Administration, Oral; Animals; Benzopyrans; Biological Availability; Catalepsy; Cyclopentanes; Dogs; Drug Discovery; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Excitatory Amino Acid Antagonists; Female; Half-Life; Indicators and Reagents; Isomerism; Ligation; Macaca mulatta; Male; Neuralgia; Oxadiazoles; Parkinson Disease; Piperidines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Nerves | 2011 |
In vitro effects of pentifin on some neurotransmitter systems in the brain.
Topics: Amino Alcohols; Animals; Brain; Cyclopentanes; Dopamine Antagonists; In Vitro Techniques; Intestine, Small; Male; Neurotransmitter Agents; Parkinson Disease; Piperidines; Rats; Receptors, Dopamine; Seminal Vesicles; Vas Deferens | 2003 |
A case of Parkinson's disease treated with parpanit.
Topics: Cyclopentanes; Parkinson Disease; Parkinsonian Disorders | 1949 |
[Parpanit in the treatment of Parkinson disease (transl)].
Topics: Cyclopentanes; Parkinson Disease; Parkinsonian Disorders | 1949 |
[Treatment of paralysis agitans with some new preparations: parpanit, diparcol, and phenergan].
Topics: Cyclopentanes; Histamine; Parkinson Disease; Parkinsonian Disorders; Phenothiazines; Promethazine | 1950 |
Parpanit in the treatment of Parkinson's disease.
Topics: Cyclopentanes; Humans; Parkinson Disease; Parkinsonian Disorders | 1949 |
Treatment of Parkinson's disease with parpanit; a preliminary report.
Topics: Cyclopentanes; Humans; Parkinson Disease; Parkinsonian Disorders | 1948 |
Artane in the treatment of Parkinson's disease; a report of its effectiveness alone and in combination with benadryl and parpanit.
Topics: Cyclopentanes; Diphenhydramine; Parkinson Disease; Parkinsonian Disorders; Trihexyphenidyl | 1949 |
Bilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra.
Topics: Animals; Cyclopentanes; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Ginkgolides; Male; Neurons; Neuroprotective Agents; NF-kappa B; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics | 2008 |